Green light for first combination vaccination against Covid and flu

The EU Commission must now officially grant this approval. But that is considered a formality. After approval by the EU Commission, the individual member states decide whether they want to offer the product.

Proven vaccines

According to the EMA, the active ingredient mCombriax from the US manufacturer Moderna works like other vaccines. It prepares the body against a possible virus infection: The preparation contains mRNA-based building blocks to ward off the corona virus and also three types of influenza. The vaccines that have now been combined were approved several years ago.

Both flu and Covid-19 can primarily affect the respiratory tract with similar symptoms such as fever, cough, runny nose and chills. In most cases, the infections are mild. But they can be particularly dangerous for older people and those with a weakened immune system. So far, they have been able to protect themselves from this with two separate vaccinations every year. A combination vaccination can relieve the burden on the health system.

effect proven

The EMA points out that studies with 8,000 people over 50 years of age have proven its effectiveness. Those people who were vaccinated with the combination preparation showed just as high a level of protection as the comparison group who were injected with two separate vaccines.

According to the EMA, possible side effects of the vaccination include pain at the injection site, fatigue, muscle aches and headaches, nausea or fever. These symptoms could last two or three days.